BMY
BRISTOL MYERS SQUIBB CONon-compliant · 0/100
Sector: Healthcare · Industry: Drug Manufacturers - General · Data as of 2026-02-11
BRISTOL MYERS SQUIBB CO is not compliant: one screen did not pass.
It clears the financial screens: interest income vs. revenue is 1.22% against a 5% limit, and cash & interest-bearing assets vs. market cap is 9.23% against a 33% limit. Nothing in the arithmetic is close to a threshold.
interest-bearing debt / market cap = 40.02% (≥ 33% limit).
Screening standard
The evidence
| Test | Figure | Limit | Source |
|---|---|---|---|
| Passed: Business activityBusiness activity is compliant. | compliant | ||
| Failed: Debt vs. market capinterest-bearing debt / market cap = 40.02% (≥ 33% limit). | 40.02% | < 33.00% | |
| Passed: Interest income vs. revenueinterest income / total revenue = 1.22% (< 5% limit). | 1.22% | < 5.00% | |
| Passed: Cash & interest-bearing assets vs. market cap(cash + interest-bearing securities) / market cap = 9.23% (< 33% limit). | 9.23% | < 33.00% |
Every number, sourced
Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.
| Figure | Value | Source |
|---|---|---|
| Total revenueRevenues | $48.2B | |
| Interest-bearing debtLong term debt | $44.8B | |
| Cash & interest-bearing securities3 components | $10.3B | |
| Interest incomeInvestment income interest | $586.0M | |
| Total assetsAssets | $90.0B | |
| ReceivablesAccounts receivable net current | $9.6B | |
| Shares outstandingEntity common stock shares outstanding | 2.0B shares | |
| Priceyahoo:24mo-trailing-avg | $54.854 |
Dividend purification
Est. 1.22% of dividends should be purified.
Price
Values & Controversies
Separate from the shariah verdict above — always.
No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we line.